Defining the role of abciximab for acute coronary syndromes: Lessons from CADILLAC, ADMIRAL, GUSTO IV, GUSTO V, and TARGET

Medicine and Dentistry

• Acute Coronary Syndrome 100%
• Abciximab 100%
• Reperfusion Therapy 40%
• Thrombocyte Activation 20%
• Clinical Trial 20%
• Thrombin 20%
• Myocardial Infarction 20%
• Blood Clotting 20%
• Pathophysiology 20%
• ST Elevation 20%
• Antiplatelet 20%
• Embolization 20%
• Coronary Microvasculature 20%
• Antithrombotic Activity 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Coronary Syndrome 100%
• Abciximab 100%
• Clinical Trial 20%
• Antithrombotic Activity 20%
• Antiplatelet 20%
• Heart Infarction 20%
• Thrombin 20%
• Thrombus 20%
• Pathophysiology 20%